ReviewJournal of Taibah University Medical Sciences2026
Platelet-to-lymphocyte ratio and mean platelet volume in recurrent aphthous stomatitis: Systematic review and meta-analysis of group differences.
Review in Journal of Taibah University Medical Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Haematological parameters are frequently employed to predict the clinicalcourse and prognosis of Recurrent aphthous stomatitis (RAS). This systematic review andmeta-analysis synthesise evidence regarding whether platelet-to-lymphocyte ratio (PLR) andmean platelet volume (MPV) differ significantly between individuals with RAS and healthycontrols. Methods: Relevant publications were identified through searches of PubMed, Embase,Scopus, EBSCOhost, and Web of Science. Results are reported as standardised meandifferences (SMDs) with 95% confidence intervals (CIs). A random-effects model wasapplied to address significant heterogeneity affecting pooled effect size interpretation. Risk ofbias was assessed using the Newcastle-Ottawa Scale, and evidence quality was evaluatedwith the GRADE approach. Results: A total of seventeen articles reporting MPV and PLR data were included in themeta-analysis to assess differences between RAS patients and healthy controls. MPV washigher in RAS patients (SMD = 0.42; 95% CI: -0.53 to 1.36), although substantialheterogeneity was observed. Recomputed MPV was only marginally higher in RAS patients(SMD = 0.01; 95% CI: -0.31 to 0.32). The study population was the only significantmoderator of the pooled effect size. PLR values were also only slightly higher in RASpatients (SMD = 0.04; 95% CI: -0.06 to 0.14), with low to moderate heterogeneity. GRADEevidence quality was rated very low for computed MPV and low for PLR. A meta-analysisdemonstrates no significant difference in mean platelet volume or platelet-lymphocyte ratiobetween RAS patients and healthy controls, underscoring the imperative to identify othersystemic factors in RAS pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.